Abstract:Polymer-drug conjugates has significantly improved the anti-tumor efficacy of chemotherapeutic drugs and alleviated their side effects. N-(1,3-dihydroxypropan-2-yl) methacrylamide (DHPMA) copolymer was synthesized via RAFT polymerization and polymer-doxorubicin (DOX) (diblock pDHPMA-DOX) were formed by conjugation, resulting in a self-aggregation-induced nanoprodrug with a favorable size of 21 nm and great stability. The nanoprodrug with a molecular weight (MW) of 95 kDa released drugs in response to tumor microenvironmental pH variations and they were enzymatically hydrolyzed into low MW segments (45 kDa). The nanoprodrug was transported through the endolysosomal pathway, released the drug into the cytoplasm and some was localized in the mitochondria, resulting in disruption of the cellular actin cytoskeleton. Cellular apoptosis was also associated with reduction in the mitochondria! potential caused by the nanoprodrug. Notably, the nanoprodrug had a significantly prolonged blood circulation time with an elimination half time of 9.8 h, displayed high accumulation within tumors, and improved the in vivo therapeutic efficacy against 4T1 xenograft tumors compared to free DOX. The tumor xenograft immunohistochemistry study clearly indicated tumor inhibition was through the inhibition of cell proliferation and antiangiogenic effects. Our studies demonstrated that the diblock pDHPMA-DOX nanoprodrug with a controlled molecular structure is promising to alleviate adverse effects of free DOX and have a great potential as an efficient anticancer agent. Statement of Significance In this work, we prepared a biodegradable diblock DHPMA polymer-doxorubicin conjugate via one-pot of RAFT polymerization and conjugate chemistry. The conjugate-based nanoprodrug was internalized by endocytosis to intracellularly release DOX and further induce disruption of mitochondrial functions, actin cytoskeleton alterations and cellular apoptosis. The nanoprodrug with a high molecular weight (MW) (95 kDa) showed a long blood circulation time and achieved high accumulation into tumors. The nanoprodrug was degraded into low MW (similar to 45 kDa) products below the renal threshold, which ensured its biosafety. Additionally, the multi-stimuli-responsive nanoprodrug demonstrated an enhanced antitumor efficacy against 4T1 breast tumors and alleviated side effects, showing a great potential as an efficient and safe anticancer agent. (C) 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

A degradable brush polymer–drug conjugate for pH-responsive release of doxorubicin

A hyperbranched amphiphilic acetal polymer for pH-sensitive drug delivery

Polylactide-graft-doxorubicin nanoparticles with precisely controlled drug loading for pH-triggered drug delivery.

Well-Defined Diblock Poly(ethylene glycol)-b-Poly(ε-caprolactone)-Based Polymer-Drug Conjugate Micelles for pH-Responsive Delivery of Doxorubicin

Polymer-Doxorubicin Prodrug with Biocompatibility, Ph Response, and Main Chain Breakability Prepared by Catalyst-Free Click Reaction.

Degradable and biocompatible aldehyde-functionalized glycopolymer conjugated with doxorubicin via acid-labile Schiff base linkage for pH-triggered drug release

Enzyme/pH-sensitive Polyhpma-Dox Conjugate As a Biocompatible and Efficient Anticancer Agent

Well-Defined Degradable Brush Polymer–Drug Conjugates for Sustained Delivery of Paclitaxel

A novel delivery system of doxorubicin with high load and pH-responsive release from the nanoparticles of poly (α,β-aspartic acid) derivative.

Acid-Responsive and Biologically Degradable Polyphosphazene Nanodrugs for Efficient Drug Delivery

Synthesis and pH-responsive self-assembly behavior of a fluorescent amphiphilic triblock copolymer mPEG-b-PCL-b-PDMAEMA-g-PC for the controlled intracellular delivery of doxorubicin

A Polyrotaxane-based Ph-Labile Drug Delivery System

Synthesis and Characterization of Biodegradable Ph and Reduction Dual-Sensitive Polymeric Micelles for Doxorubicin Delivery

Biocompatible and acid-cleavable poly(ε-caprolactone)-acetal-poly(ethylene glycol)-acetal-poly(ε-caprolactone) triblock copolymers: synthesis, characterization and pH-triggered doxorubicin delivery.

Enzyme- and Ph-Sensitive Branched Polymer-Doxorubicin Conjugate-Based Nanoscale Drug Delivery System for Cancer Therapy

Polyphosphazene nanoparticles for cytoplasmic release of doxorubicin with improved cytotoxicity against Dox-resistant tumor cells.

Ph-Responsive Expandable Polycarbonate-Doxorubicin Conjugate Nanoparticles For Fast Intracellular Drug Release

A Ph-Sensitive Nano Drug Delivery System Of Doxorubicin-Conjugated Amphiphilic Polyrotaxanebased Block Copolymers

A Biomimic Ph-Sensitive Polymeric Prodrug Based on Polycarbonate for Intracellular Drug Delivery

Stimuli-responsive Polymer-Doxorubicin Conjugate: Antitumor Mechanism and Potential As Nano-Prodrug.

Biocompatible And Acid-Cleavable Poly(Epsilon-Caprolactone)-Acetal-Poly(Ethylene Glycol)-Acetal-Poly(Epsilon-Caprolactone) Triblock Copolymers: Synthesis, Characterization And Ph-Triggered Doxorubicin Delivery